- Home
- MDGL vs HIMS Comparison
MDGL vs HIMS Comparison
Compare MDGL & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- HIMS
- Stock Information
- Founded
- MDGL 2011
- HIMS 2017
- Country
- MDGL United States
- HIMS United States
- Employees
- MDGL N/A
- HIMS N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- HIMS Medical/Nursing Services
- Sector
- MDGL Health Care
- HIMS Health Care
- Exchange
- MDGL Nasdaq
- HIMS Nasdaq
- Market Cap
- MDGL 6.1B
- HIMS 10.8B
- IPO Year
- MDGL N/A
- HIMS N/A
- Fundamental
- Price
- MDGL $427.05
- HIMS $50.87
- Analyst Decision
- MDGL Strong Buy
- HIMS Hold
- Analyst Count
- MDGL 10
- HIMS 11
- Target Price
- MDGL $474.67
- HIMS $37.20
- AVG Volume (30 Days)
- MDGL 349.9K
- HIMS 27.1M
- Earning Date
- MDGL 10-30-2025
- HIMS 11-03-2025
- Dividend Yield
- MDGL N/A
- HIMS N/A
- EPS Growth
- MDGL N/A
- HIMS 866.21
- EPS
- MDGL N/A
- HIMS 0.79
- Revenue
- MDGL $515,547,000.00
- HIMS $2,013,538,000.00
- Revenue This Year
- MDGL $394.12
- HIMS $61.80
- Revenue Next Year
- MDGL $57.74
- HIMS $19.38
- P/E Ratio
- MDGL N/A
- HIMS $64.49
- Revenue Growth
- MDGL 3421.98
- HIMS 88.69
- 52 Week Low
- MDGL $200.63
- HIMS $15.73
- 52 Week High
- MDGL $457.16
- HIMS $72.98
- Technical
- Relative Strength Index (RSI)
- MDGL 59.53
- HIMS 53.61
- Support Level
- MDGL $418.36
- HIMS $47.48
- Resistance Level
- MDGL $440.90
- HIMS $56.52
- Average True Range (ATR)
- MDGL 13.53
- HIMS 3.10
- MACD
- MDGL -4.66
- HIMS 1.18
- Stochastic Oscillator
- MDGL 22.40
- HIMS 64.07
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About HIMS Hims & Hers Health Inc.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.